文献速递重症综合管理与镇静镇痛

2021年法国重症医学会学术会议的卫生安全:一项病例对照研究

Sanitary safety of the 2021 French Intensive Care Society medical conference: a case/control study.
PubMed 文献 · Ann Intensive Care · 2022-02-11
一句话结论在低发病率时期,参会者第7天SARS-CoV-2侧流检测无阳性,匹配对照亦无感染,提示线下大型会议未增加感染风险。

本研究为前瞻性观察性研究,纳入2021年6月9日至11日在巴黎举行的法国重症医学会(FICS)年会参会者及匹配对照(会议期间留守ICU的医护人员)。参会者需满足法律要求:接种第二剂疫苗后≥7天或72小时内PCR检测阴性。第7天进行SARS-CoV-2侧流检测,随访至第21天。1824名参会者中520人(28.5%)同意参与,216人(41.5%)获得随访数据,匹配对照191人。参会者和对照均未报告SARS-CoV-2侧流检测阳性。参会者感染概率低于1.7%(95%CI [0;1.7%]),对照低于2%(95%CI [0;2%]),感染概率差异低于1.9%(95%CI [0;1.9%])。作者认为在低发病率时期,该参会人群第7天侧流检测未发现阳性病例,匹配对照亦无感染,提示大型会议未增加感染风险。

要点

  • 1824名参会者均符合法律要求(接种第二剂疫苗后≥7天或72小时内PCR阴性),其中520人(28.5%)同意参与研究。
  • 参会者第7天SARS-CoV-2侧流检测无阳性,感染概率低于1.7%(95%CI [0;1.7%])。
  • 匹配对照(会议期间留守ICU的医护人员)无阳性,感染概率低于2%(95%CI [0;2%])。
  • 参会者与对照的感染概率差异低于1.9%(95%CI [0;1.9%])。
  • 作者认为在低发病率时期,线下大型会议未增加SARS-CoV-2感染风险。

适用人群与场景

  • 2021年6月9日至11日在巴黎举行的法国重症医学会(FICS)年会参会者(医护人员),且满足法律要求:接种第二剂疫苗后≥7天或72小时内PCR检测阴性。
  • 匹配对照为会议期间留守ICU的医护人员。

研究设计与关键结果

  • 研究类型:前瞻性观察性研究(病例对照设计),纳入FICS年会参会者及匹配对照。
  • 参会者1824人,其中520人(28.5%)同意参与;获得随访数据216人(41.5%),匹配对照191人。
  • 第7天SARS-CoV-2侧流检测:参会者和对照均无阳性报告。
  • 参会者感染概率低于1.7%(95%CI [0;1.7%]);对照低于2%(95%CI [0;2%]);差异低于1.9%(95%CI [0;1.9%])。
  • 随访至第21天。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究(病例对照研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在低发病率时期,对于符合法律要求(接种第二剂疫苗后≥7天或72小时内PCR阴性)的医护人员,线下大型会议未显示增加SARS-CoV-2感染风险(作者认为)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In-person mass gathering events (MGE) are returning after a period of restrictions, yet few prospective scientific evaluations of their safety are available.

METHODS: Prospective observational study, including both attendees of the French Intensive Care Society (FICS) annual meeting held in Paris between June the 9th and June the 11th, 2021 and matched controls (healthcare professionals who stayed in the ICU during the conference). SARS-CoV-2 lateral flow test was performed on day 7. Follow-up occurred until day 21.

RESULTS: Out of the 1824 healthcare professionals attending the congress (all of which fulfilled legal requirements: 7 days or more following a second dose of vaccine or a negative PCR test performed within less than 72 h), 520 (28.5%) agreed to participate. Follow-up data were received for 216 (41.5%) out of the 520 included attendees, and for 191 matched controls. No positive SARS-CoV-2 lateral flow test was reported in the attendees or in the matched controls. The probability of SARS-CoV-2 infection during the MGE was less than 1.7% in the attendees (95% confidence interval [0;1.7%]), less than 2% in the controls (95%CI [0;2%]) and the difference in probabilities of infection was less than 1.9% (95% CI [0;1.9%]).

CONCLUSION: During a low incidence period, in this population of congress attendees screened for SARS-CoV-2 by a lateral flow test at day 7, no positive cases could be documented, no concomitant infection occurred in the matched controls; suggesting no extra risk of infection during the MGE.

TRIAL REGISTRATION: ClinicalTrial.gov, #NCT04918160.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Sanitary safety of the 2021 French Intensive Care Society medical conference: a case/control study. Ann Intensive Care. 2022. PMID: 35147794. doi:10.1186/s13613-022-00986-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。